Getting to know GH&B

• Global Hospital & Biosimilars (GH&B) makes the products that are thefoundationof hospital care–sterile injectables and biosimilars–thatreachmore than 100 million patients annually, generating$5 billionin revenue for Pfizer. These are not niche products; they are for when patients are at the most vulnerable, essential to access and acute care delivery worldwide.

• GH&B is Pfizer's only truly end-to-end business, spanning fromour 12 globalmanufacturingsitesthrough tocommercial in a single integrated organization. It was created to give this portfolio dedicated focus, clearer accountability, and a fit-for-purpose operating model–recognizing that GH&B's portfolio has different economics, customer dynamics, and execution needs than Pfizer's innovative business.

• By bringing Commercial and Supply into one organization, GH&B enables faster decision-making, stronger prioritization, and expanded capabilities for this important portfolio.

• Our ambition: Rebuild a healthy operation positioned to serve patients for generations to come

Use Your Power for Purpose

• The Commercial Director Biosimilarsleads the commercial strategy and performanceof Pfizer's biosimilar franchise across GH&B international markets. The role sets above-market direction for portfolio optimization, tendering and pricing, and demand-supply alignmentin a highly competitive, tender-driven environment translating global portfolio strategy into execution across a diverse set of geographies and market archetypes.

• This is a high-impact leadership role at the intersection of strategy and execution: the Commercial Director will drive performance across markets without direct-line authority, leveraging analytics, cross-functional partnerships, and a deep understanding of biosimilar economics to unlock incremental value and accelerate growth.

What You Will Achieve

Strategic Leadership & Portfolio Direction

• Co-develop the overarching biosimilar portfolio strategy including lifecycle management, product prioritization, and market entry/exit decisions in price-sensitive, tender-driven environments in close alignment with relevant global stakeholders

• Lead execution of thebiosimilarscommercial strategy across GH&B international markets, ensuring alignment with enterprise priorities and the GH&B International Commercial operating model

• Identifykey performance drivers and unlock incremental value through portfolio/margin optimization, tendering & contracting excellence, and market-specific initiatives in partnership with global, international, and local stakeholders

Performance Management & Capability Development

• Drive the performance management cadence for thebiosimilarsportfolio across international markets, including monthly/LE reviews and structured market deep-dives

• Partner with local market teams to assess YTD performance,validateforecasts, andidentifyrisks, opportunities, and mitigation plans

• Provideabove-market guidance on execution priorities and performance acceleration initiatives

• Strengthen international commercial capabilities through tools, frameworks, and best-practice sharing across the GH&B international markets community, in close partnership with the Commercial Director for Hospital

• Foster a high-performance, collaborative culture across a heterogeneous, geographically dispersed biosimilar market community

Tendering & Contracting Strategy and Pricing Oversight

• Contribute to the development of the biosimilars tendering & contracting strategy for international markets

• Oversee governance and escalation for key market-level tender, pricing, and access decisions (e.g., list price adjustments) with material P&L impact

Market Insights, Analytics & Business Planning

• Leverage analytics and market intelligence toidentifygrowth opportunities andvalidatemarket headroom for thebiosimilarsportfolio in collaboration with relevant global stakeholders

• Ensure data-driven decision-making and prioritization of high-impact initiatives across the portfolio

• Act as sparring partner for local markets in business planning processes, providing perspective on market-level drivers, competitive dynamics, and policy impacts

Cross-Functional Leadership & Governance

• Act as portfolio steward for biosimilars within the GH&B end-to-end model, bridging Commercial, Supply, Finance, Regulatory, and Access functions

• Ensure alignment across global, international, and local market stakeholders on strategic priorities and execution plans

Supply, Demand & Operational Excellence

• Represent international market needs in IBP processes, including discussions on supply/demand trade-offs, tender participation decisions, and mitigation of stock-outs or supply risks

• Contribute to the optimization of GH&B end-to-end processes (plant-to-patient) to improve execution efficiency and supply reliability

Market Development & Execution Support

• Enable local markets to maximize biosimilar uptake through tailored strategies, account management insights, and tender participation guidance

• Identifyresourcing and capability gaps in markets and advocate for targeted investments to unlock growth

• Support key product launches, transitions, and lifecycle events across the portfolio

Technology & AI Enablement

• Champion adoption of AI-enabled tools and advanced analytics across the biosimilar market community to accelerate insight generation, improve forecast accuracy, and support data-driven tender and pricing decisions

• Demonstrate strong personal digital literacy and AI fluency, modelling practical use of data, digital tools,and AI-enabled solutions

• Partner with Commercial Performance, Data & Analytics, and IT teams to define reporting and tooling requirements that enable scalable, real-time performance visibility across international markets

• Identifyopportunities for automation and digital transformation in biosimilar commercial processes (e.g., tender tracking, competitive monitoring, demand signaling) and advocate for prioritized investment

• Ensure responsible use of AI throughappropriate governanceand human oversight, aligned with GH&B and enterprise standards

What you need to achieve this:

• Leading Through Change:Demonstratedexperience leading leaders and teams through complex change, including navigating ambiguity, influencing across stakeholders, and sustaining performance during transformation

• End-to-End Process Thinking: Proven ability to think andoperateend-to-end, connecting strategy to execution across functions andanticipatingdownstream impacts to deliver integrated, enterprise-level solutions

Here Is What You Need (Minimum Requirements)

• Bachelor's degree in Business, Life Sciences, Economics, or related field; MBA or relevant advanced degree preferred

• 12+ years of progressive commercial experience in pharmaceuticals, biosimilars, or generics, with significant exposure to international/multi-market environments

• Deepexpertisein biosimilar or generics commercial models, including tender-driven markets, pricing dynamics, and competitive portfolio management

• Demonstratedtrack recordin above-market or regional commercial leadership roles with portfolio P&L influence

• Strong commercial acumen with proven ability to translate analytics and market intelligence into growth strategies and execution priorities

• Experience in cross-functional leadership across Commercial, Supply, Finance, and Market Access

• Fluency in Englishrequired;additionallanguages an asset

Bonus points if you have (preferred requirements)

• Master's degree with relevant pharmaceutical industry experience

• Direct experience in biosimilar launches and lifecycle management across multiple geographies

• Background in tendering & contracting strategy or pricing governance in international markets

• Experience working within integrated end-to-end business models (commercial + supply)

• Track recordof building commercial capabilities and communities of practice across dispersed teams

• Familiarity with IBP/S&OP processes and demand-supply integration

• Experience navigating complex stakeholder environments across global, regional, and local levels

Other Job details:

Work location: Hybrid

Last date to apply: September 11, 2026